REAL-WORLD EXPERIENCE OF GLECAPREVIR/PIBRENTASVIR TREATMENT IN JAPANESE ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

被引：0

作者：

Mizuochi, Tatsuki ^{[1
]}

Iwama, Itaru ^{[2
]}

Inui, Ayano ^{[3
]}

Ito, Yoshinori ^{[4
]}

Takaki, Yugo ^{[5
]}

Mushiake, Sotaro ^{[6
]}

Tokuhara, Daisuke ^{[7
]}

Ishige, Takashi ^{[8
]}

Ito, Koichi ^{[9
]}

Murakami, Jun ^{[10
]}

Hishiki, Haruka ^{[11
]}

Mikami, Hitoshi ^{[12
]}

Bessho, Kazuhiko ^{[13
]}

Kato, Ken ^{[1
]}

Yasuda, Ryosuke ^{[1
]}

Yamashita, Yushiro ^{[1
]}

Tanaka, Yasuhito ^{[14
,15
,16
]}

Tajiri, Hitoshi ^{[17
]}

机构：

[1] Kurume Univ, Pediat & Child Hlth, Sch Med, Kurume, Fukuoka, Japan

[2] Saitama Childrens Med Ctr, Gastroenterol & Hepatol, Saitama, Japan

[3] Saiseikai Yokohamashi Tobu Hosp, Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan

[4] Nagoya Univ, Pediat, Grad Sch Med, Nagoya, Aichi, Japan

[5] Japanese Red Cross Kumamoto Hosp, Pediat, Kumamoto, Japan

[6] Kindai Univ, Pediat, Nara Hosp, Higashiosaka, Osaka, Japan

[7] Osaka City Univ, Pediat, Grad Sch Med, Osaka, Japan

[8] Gunma Univ, Pediat, Grad Sch Med, Gunma, Japan

[9] Nagoya City Univ, Grad Sch Med Sci, Pediat & Neonatol, Nagoya, Aichi, Japan

[10] Tottori Univ, Pediat & Perinatol, Fac Med, Tottori, Japan

[11] Chiba Univ Hosp, Pediat, Chiba, Japan

[12] Iwate Prefectural Cent Hosp, Pediat, Morioka, Iwate, Japan

[13] Osaka Univ, Grad Sch Med, Pediat, Osaka, Japan

[14] Kumamoto Univ, Dept Gastroenterol & Hepatol, Fac Life Sci, Kumamoto, Japan

[15] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan

[17] Kindai Univ, Pediat, Fac Med, Higashihiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4803

引用

页码：S1524 / S1525

页数：2

共 50 条

[31] Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
Toyoda, Hidenori
Chayama, Kazuaki
Suzuki, Fumitaka
Sato, Ken
Atarashi, Tomofumi
Watanabe, Tsunamasa
Atsukawa, Masanori
Naganuma, Atsushi
Notsumata, Kazuo
Osaki, Yukio
Nakamuta, Makoto
Takaguchi, Koichi
Saito, Satoru
Kato, Koji
Pugatch, David
Burroughs, Margaret
Redman, Rebecca
Alves, Katia
Pilot-Matias, Tami J.
Oberoi, Rajneet K.
Fu, Bo
Kumada, Hiromitsu
HEPATOLOGY, 2018, 67 (02) : 505 - 513
[32] Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/ pibrentasvir for genotype 6 chronic hepatitis C
Chen, Jyh-Jou
Chiu, Yen-Cheng
Lee, Pei-Lun
Tung, Hung-Da
Chiu, Hung-Chih
Chien, Shih-Chieh
Cheng, Pin-Nan
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (11) : 2265 - 2272
[33] Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?
Zarebska-Michaluk, Dorota
Jaroszewicz, Jerzy
Pabjan, Pawel
Lapinski, Tadeusz W.
Mazur, Wlodzimierz
Krygier, Rafal
Dybowska, Dorota
Halota, Waldemar
Pawlowska, Malgorzata
Janczewska, Ewa
Buczynska, Iwona
Simon, Krzysztof
Dobracka, Beata
Citko, Jolanta
Laurans, Lukasz
Tudrujek-Zdunek, Magdalena
Tomasiewicz, Krzysztof
Piekarska, Anna
Sitko, Marek
Bialkowska-Warzecha, Jolanta
Klapaczynski, Jakub
Sobala-Szczygiel, Barbara
Horban, Andrzej
Berak, Hanna
Deron, Zbigniew
Lorenc, Beata
Socha, Lukasz
Tronina, Olga
Flisiak, Robert
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (07) : 1944 - 1952
[34] Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C-Results of a Multicenter EpiTer-2 Study
Pawlowska, Malgorzata
Dobrowolska, Krystyna
Moppert, Justyna
Pokorska-Spiewak, Maria
Purzynska, Mariola
Marczynska, Magdalena
Zarebska-Michaluk, Dorota
Flisiak, Robert
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
[35] ADDRESSING BARRIERS TO HEPATITIS C VIRUS (HCV) ELIMINATION: REAL-WORLD OUTCOMES IN HISTORICALLY UNDERSERVED PATIENTS WITH CHRONIC HCV INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR
Lampertico, Pietro
Peck-Radosavljevic, Markus
Bondin, Mark I.
Mazur, Wlodzimierz
Magenta, Lorenzo
Foucher, Juliette
Porcalla, Ariel
Crown, Eric D.
Jalundhwala, Yash
Zhang, Zhenzhen
Mimidis, Konstantinos
Hazzan, Rawi
Marques, Nuno
Bourgeois, Stefan
HEPATOLOGY, 2019, 70 : 954A - 955A
[36] Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Forns, Xavier
Feld, Jordan J.
Dylla, Douglas E.
Pol, Stanislas
Chayama, Kazuaki
Hou, Jinlin
Heo, Jeong
Lampertico, Pietro
Brown, Ashley
Bondin, Mark
Tatsch, Fernando
Burroughs, Margaret
Marcinak, John
Zhang, Zhenzhen
Emmett, Amanda
Gordon, Stuart C.
Jacobson, Ira M.
ADVANCES IN THERAPY, 2021, 38 (06) : 3409 - 3426
[37] A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection
Tomiyasu, Hiroka
Nakajima, Saeko
Kaku, Yo
Hirata, Masahiro
Kataoka, Tatsuki
Nomura, Takashi
Kabashima, Kenji
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 93 - 95
[38] Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Xavier Forns
Jordan J. Feld
Douglas E. Dylla
Stanislas Pol
Kazuaki Chayama
Jinlin Hou
Jeong Heo
Pietro Lampertico
Ashley Brown
Mark Bondin
Fernando Tatsch
Margaret Burroughs
John Marcinak
Zhenzhen Zhang
Amanda Emmett
Stuart C. Gordon
Ira M. Jacobson
Advances in Therapy, 2021, 38 : 3409 - 3426
[39] Real-world Effectiveness of Glecaprevir/Pibrentasvir (GLE/PIB) for Chronic Hepatitis C Infection: Evidence From a German Single-center Cohort Study
Beisel, Claudia
Herrmann, Marissa
Piecha, Felix
Lampalzer, Sibylle
Buescher, Gustav
Pischke, Sven
Wiesch, Julian Schulze zur
HEPATITIS MONTHLY, 2021, 21 (01)
[40] A real-world clinical application of the combination therapy with glecaprevir/pibrentasvir to special population in chronic hepatitis C patients
Sato, Ken
Yamazaki, Yuichi
Kobayashi, Takeshi
Tojima, Hiroaki
Horiguchi, Norio
Kakizaki, Satoru
Uraoka, Toshio
Ohnishi, Hiroshi
Okamoto, Hiroaki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 444 - 444

← 1 2 3 4 5 →